Catherine Kopil

2.9k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Catherine Kopil is a scholar working on Neurology, Economics and Econometrics and Psychiatry and Mental health. According to data from OpenAlex, Catherine Kopil has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 5 papers in Economics and Econometrics and 5 papers in Psychiatry and Mental health. Recurrent topics in Catherine Kopil's work include Parkinson's Disease Mechanisms and Treatments (22 papers), Neurological disorders and treatments (11 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Catherine Kopil is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (22 papers), Neurological disorders and treatments (11 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Catherine Kopil collaborates with scholars based in United States, Canada and United Kingdom. Catherine Kopil's co-authors include Caroline M. Tanner, Nabila Dahodwala, E. Ray Dorsey, Roger L. Albin, Inna Cintina, James C. Beck, Wenya Yang, Ted Thompson, Jamie Hamilton and Paul Hogan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Catherine Kopil

28 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current and projected future economic burden of Parkinson’s disease in the U.S.

2020 397 citations Wenya Yang, Jamie Hamilton et al. npj Parkinson s Disease profile →

Peers

Catherine Kopil

NEURO

CMN

PHYSI

NEURO

Lisa Klingelhoefer Germany

Jared T. Hinkle United States

Denise I. Briggs United States

Yasushi Shimo Japan

Giulio Riboldazzi Italy

Minjee Kook United States

Esen Saka Türkiye

Zoe Katsarou Greece

Katie Kompoliti United States

Nil Dizdar Sweden

Lisa Klingelhoefer Germany

Catherine Kopil

902 ×1.5

NEURO

242 ×1.0

CMN

170 ×1.0

188 ×1.3

PHYSI

148 ×1.0

NEURO

Citations per year, relative to Catherine Kopil Catherine Kopil (= 1×) peers Lisa Klingelhoefer

Countries citing papers authored by Catherine Kopil

Since Specialization

Citations

This map shows the geographic impact of Catherine Kopil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Kopil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Kopil more than expected).

Fields of papers citing papers by Catherine Kopil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Kopil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Kopil. The network helps show where Catherine Kopil may publish in the future.

Co-authorship network of co-authors of Catherine Kopil

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Kopil. A scholar is included among the top collaborators of Catherine Kopil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Kopil. Catherine Kopil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lowe, Naomi, et al.. (2025). Fears and uncertainties of people with Parkinson's disease. Journal of Parkinson s Disease. 15(3). 595–602.

Simuni, Tanya, Caroline Gochanour, Michael C. Brumm, et al.. (2025). Neuronal α‐Synuclein Disease Stage Progression over 5 Years. Movement Disorders. 40(7). 1318–1330.

Mancini, Martina, Jeffrey M. Hausdorff, Elisa Pelosin, et al.. (2025). A framework to standardize gait study protocols in Parkinson's disease. Journal of Parkinson s Disease. 15(1). 129–139. 1 indexed citations

Kopil, Catherine, Sohini Chowdhury, David T. Dexter, et al.. (2024). A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders. Journal of Parkinson s Disease. 14(6). 1105–1114. 2 indexed citations

Mestre, Tiago, Glenn T. Stebbins, Diane Stephenson, et al.. (2024). Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advances. npj Parkinson s Disease. 10(1). 101–101. 4 indexed citations

Mantri, Sneha, Steven M. Albert, Margaret Daeschler, et al.. (2021). Triggers and alleviating factors for fatigue in Parkinson’s disease. PLoS ONE. 16(2). e0245285–e0245285. 19 indexed citations

Chahine, Lana M., Robert Feldman, Andrew D. Althouse, et al.. (2021). Contribution of neuropsychiatric symptoms in Parkinson’s disease to different domains of caregiver burden. Journal of Neurology. 268(8). 2961–2972. 16 indexed citations

Mantri, Sneha, et al.. (2021). The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating Factors. SHILAP Revista de lepidopterología. 8(3). 232–238. 7 indexed citations

Mantri, Sneha, Steven M. Albert, Stephen B. Kahl, et al.. (2020). Understanding the Lexicon of Fatigue in Parkinson’s Disease. Journal of Parkinson s Disease. 10(3). 1185–1193. 11 indexed citations

10.

Yang, Wenya, Jamie Hamilton, Catherine Kopil, et al.. (2020). Current and projected future economic burden of Parkinson’s disease in the U.S.. npj Parkinson s Disease. 6(1). 15–15. 397 indexed citations breakdown →

11.

Dobkin, Roseanne D., Ninad Amondikar, Catherine Kopil, et al.. (2020). Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort Experience. Journal of Parkinson s Disease. 10(2). 665–675. 32 indexed citations

12.

Chahine, Lana M., Thomas G. Beach, Michael C. Brumm, et al.. (2020). In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology. 95(9). e1267–e1284. 95 indexed citations

13.

Luo, Lan, Howard Andrews, Roy N. Alcalay, et al.. (2019). Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism & Related Disorders. 65. 178–183. 20 indexed citations

14.

Nguyen, Andrew, et al.. (2018). Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross sectional Analysis of the MJFF Fox Insight (FI) Platform (P2.056). Neurology. 90(15_supplement). 1 indexed citations

15.

Eidson, Lori N., George T. Kannarkat, Christopher J. Barnum, et al.. (2017). Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease. Journal of Neuroinflammation. 14(1). 164–164. 69 indexed citations

16.

Biglan, Kevin, et al.. (2017). Increasing Efficiency of Recruitment in Early Parkinson’s Disease Trials: A Case Study Examination of the STEADY-PD III Trial. Journal of Parkinson s Disease. 7(4). 685–693. 17 indexed citations

17.

Gullotti, David, Catherine Kopil, Ted Abel, et al.. (2016). Primary blast injury causes cognitive impairments and hippocampal circuit alterations. Experimental Neurology. 283(Pt A). 16–28. 35 indexed citations

18.

Kopil, Catherine, Adam P. Siebert, J. Kevin Foskett, & Robert W. Neumar. (2012). Calpain‐cleaved type 1 inositol 1,4,5‐trisphosphate receptor impairs ER Ca²⁺ buffering and causes neurodegeneration in primary cortical neurons. Journal of Neurochemistry. 123(1). 147–158. 17 indexed citations

19.

Bevers, Matthew B., Jeffrey T. Cole, Luchuan Li, et al.. (2010). RNAi targeting µ-calpain increases neuron survival and preserves hippocampal function after global brain ischemia. Experimental Neurology. 224(1). 170–177. 23 indexed citations

20.

Kozorovitskiy, Yevgenia, et al.. (2005). Experience induces structural and biochemical changes in the adult primate brain. Proceedings of the National Academy of Sciences. 102(48). 17478–17482. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact